Notify me when STEINMAN LAWRENCE files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | Common Stock, par value $0.0001 per share | 3.1% | $141,720 | 83,858 | Lawrence Steinman | 01 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|